Immediate Impact
1 from Science/Nature 15 standout
Citing Papers
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
2022 Standout
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
2022 Standout
Works of M Belo being referenced
Safety and Efficacy of Rifampin or Isoniazid Among People With Mycobacterium tuberculosis Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials
2020
Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| M Belo | 238 | 158 | 76 | 21 | 318 | |
| Eleny Guimarães Teixeira | 181 | 102 | 47 | 19 | 272 | |
| Kaio Vinícius Freitas de Andrade | 215 | 86 | 34 | 22 | 302 | |
| Danielle Talita dos Santos | 178 | 121 | 26 | 24 | 304 | |
| Wânia da Silva Carvalho | 287 | 223 | 113 | 39 | 365 | |
| Akira Shimouchi | 207 | 166 | 88 | 42 | 324 | |
| Ruoyan Gai | 85 | 139 | 31 | 26 | 329 | |
| Gillian Mann | 220 | 147 | 29 | 18 | 350 | |
| Rosa Lívia Freitas de Almeida | 115 | 87 | 35 | 43 | 304 | |
| Geeta Pardeshi | 192 | 121 | 44 | 39 | 292 | |
| Everton Ferreira Lemos | 198 | 123 | 52 | 18 | 280 |
All Works
Loading papers...